UAB "Swixx Biopharma" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data
| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 5,166,407 |
| 127,786 |
| 301,363 |
| 264,118 |
| 6,533 |
| 84.06 |
| 5.11 |
| 602,793 |
| 580,246 |
| 96,663 |
| 1,035,103 |
| 2023 |
|---|
| 5,786,464 |
| 138,797 |
| 381,645 |
| 302,989 |
| 7,268 |
| 84.57 |
| 5.24 |
| 905,783 |
| 769,783 |
| 109,242 |
| 1,466,233 |
| 2024 |
|---|
| 5,753,408 |
| 130,908 |
| 325,690 |
| 273,862 |
| 6,231 |
| 83.68 |
| 4.76 |
| 1,179,645 |
| 786,347 |
| 82,301 |
| 1,811,460 |
Register and
explore Okredo data| 2024 |
|---|
| 5,753,408 |
| 130,908 |
| 325,690 |
| 273,862 |
| 6,231 |
| 83.68 |
| 4.76 |
| 1,179,645 |
| 786,347 |
| 82,301 |
| 1,811,460 |
Register and
explore Okredo data2024
Turnover (€)
5,753,408 €
-1 % *
Sales per employee (€)
130,908 €-6 % *
Profit before tax (€)
325,690 €-15 % *
Net Profit (€)
273,862 €-10 % *
Profit per employee (€)
6,231 €-14 % *
Total profitability (%)
83.68 %-1.05 % *
Net profitability (%)
4.76 %-9.16 % *
Equity (€)
1,179,645 €
30 % *
Amounts Payable And Liabilities (€)
786,347 €
2 % *
Non-current Assets (€)
82,301 €
-25 % *
CurrentAssets (€)
1,811,460 €24 % *